Announcement: We updated MyCEI, the CEI learning management portal. Available online now! For any question contact us at: support@ceitraining.org
/-->Menu
Search
Home > Courses > Update from IAS-2018 Amsterdam, Part I: HIV Epidemiology, ART Initiation, and Switch Studies

Update from IAS-2018 Amsterdam, Part I: HIV Epidemiology, ART Initiation, and Switch Studies

Update from IAS-2018 Amsterdam, Part I: HIV Epidemiology, ART Initiation, and Switch Studies
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 8/14/2018
Termination Date: 08/13/2021
Review Date: 10/26/2018
Presenter
  • Roy M. Gulick, MD, MPH
    Rochelle Belfer Professor in Medicine Chief, Division of Infectious Diseases
    Weill Medical College of Cornell University, New York, NY
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Appreciate the latest epidemiologic data on HIV/AIDS.
  2. Be aware of the latest data from the International AIDS Society Amsterdam meeting on treatment of HIV disease.
Presenter Bio
Roy Gulick, MD, MPH
Dr. Gulick is Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine, and Attending Physician at the New York Presbyterian Hospital in New York City. Dr. Gulick’s research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess antiretroviral agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the U.S. National Institutes of Health. He also serves as the Co-Chair of the U.S. Department of Health and Human Services (DHHS) Panel on Clinical Practices for Treatment of HIV Infection, Chair of the NIH Office of AIDS Research Advisory Committee (OARAC), a Board Member of the International Antiviral Society-USA, and previously served as a Member and as Chairman of the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA).
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on August 14, 2018 and will terminate August 13, 2021.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Ron Gulick (Presenter) has no relevant financial relationships to disclose. Dr. Karen Palmore Beckerman submitted will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules